2025 Strategic Guide to the Plantar Fasciitis Treatment Market – Forecasts and Business Use Cases

 For business leaders, corporate strategists, and growth-focused teams — this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.

 
 What is the projected market size of the plantar fasciitis treatment industry, and what is its expected CAGR?
 The plantar fasciitis treatment market size has grown exponentially in recent years. It will grow from $1.68 billion in 2024 to $2.08 billion in 2025 at a compound annual growth rate (CAGR) of 24.0%. The growth in the historic period can be attributed to alternative therapies, patient education and awareness, pain management solutions, rise in sports injuries, physical therapy techniques.
 
 The plantar fasciitis treatment market size is expected to see exponential growth in the next few years. It will grow to $4.73 billion in 2029 at a compound annual growth rate (CAGR) of 22.8%. The growth in the forecast period can be attributed to regulatory changes and approvals, patient-centric approaches, research and clinical trials, focus on personalized medicine, growing aging population. Major trends in the forecast period include focused rehabilitation techniques, innovations in orthopedic devices, biomechanical studies, alternative therapies advancements, patient education and self-care.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=9385&type=smp
 
 What external factors are influencing the plantar fasciitis treatment market’s growth momentum?
 A rise in obesity is expected to propel the growth of the plantar fasciitis market going forward. Obesity is a health risk caused by an abnormal or excessive fat buildup. Overweight is defined as a body mass index (BMI) of 25 or greater and obesity as a BMI greater than 30. A person with a normal weight has a chance of acquiring plantar fasciitis that is almost six times lower than that of someone with a body mass index (BMI) of 30 or higher. For instance, data from 2022 released by the Centers for Disease Control and Prevention (CDC), a US government agency, indicate that 22 states now have an adult obesity prevalence of 35% or higher, up from 19 states in 2021. Therefore, the rise in obesity is driving the growth of the plantar fasciitis market.
 
 What are the major market segments driving the growth of the plantar fasciitis treatment industry?
 The plantar fasciitis treatment market covered in this report is segmented –
 
 1) By Type: Medication Therapy, Orthotics, Shockwave Therapy, Surgery, Other Types
 2) By Diagnosis: Medical History, Physical Examination, X-Rays, Radiography, Other Diagnosis
 3) By End User: Hospitals, Clinics, Other End Users
 
 Subsegments:
 1) By Medication Therapy: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Pain Relievers, Topical Treatments
 2) By Orthotics: Custom Orthotic Inserts, Over-The-Counter Insoles, Night Splints, Heel Cups
 3) By Shockwave Therapy: Radial Shockwave Therapy, Focused Shockwave Therapy
 4) By Surgery: Plantar Fascia Release, Gastrocnemius Recession, Other Surgical Procedures
 5) By Other Types: Physical Therapy, Massage Therapy, Stretching And Strengthening Exercises, Alternative Therapies
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/plantar-fasciitis-treatment-global-market-report
 
 What are the key trends shaping the plantar fasciitis treatment market in the forecast period?
 Technological advancements are a key trend gaining popularity in the plantar fasciitis treatment market. Major companies operating in the plantar fasciitis treatment market are developing and implementing new technologies to revolutionize treatment for plantar heel pain and expanding their geographic presence to sustain their position in the market. For instance, in December 2022, ZetrOZ Systems, a US-based ultrasound technology manufacturing company, introduced the Sam X1, the only wireless ultrasound device with FDA certification for at-home usage. The Sam X1 wireless unit can be used as a regenerative treatment alternative for soft tissue injuries and plantar fasciitis to boost cellular proliferation without the use of drugs or surgery. It has been proven effective in treating a wide range of injuries, including plantar fasciitis. The ZetrOZ sam x1 device widens blood vessels to deliver more oxygenated blood to the healing region, eliminating waste products such as cytokine enzymes and cells, and speeding up the healing process.
 
 Who are the key market players contributing to the growth of the plantar fasciitis treatment industry?
 Major companies operating in the plantar fasciitis treatment market include Bayer AG, Superfeet Worldwide LLC, Bauerfeind AG, Ottobock SE & Co. KGaA, Shapecrunch Technology Pvt. Ltd., Sanofi SA, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Scholl’s Wellness Co., Hanger Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Smith & Nephew plc, Arthrex Inc., DJO Global Co., Medline Industries Inc., Bird & Cronin Inc., Aetrex Worldwide Inc.
 
 Which regions are leading the growth of the plantar fasciitis treatment market globally?
 North America was the largest region in the plantar fasciitis treatment market in 2024. The regions covered in the plantar fasciitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 How Can Companies Use The Plantar Fasciitis Treatment Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9385
 
 Need Customized Data On Plantar Fasciitis Treatment Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=9385&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Europe: +44 207 1930 708
 
 Asia: +91 88972 63534
 
 Americas: +1 315 623 0293
 
 Email: info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company